Tirzepatide is a once-weekly injectable medication approved by the FDA for the treatment of type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management in adults with obesity or overweight with weight-related comorbidities (marketed as Zepbound)
In reality, methionine sulfoxide is a substance that has been associated with age-related oxidative damage in several occasions
Yin Z, Milatovi D, Aschner JL, Syversen T, Rocha JBTda, Souza DO, SidorykWgrzynowicz M, Albrecht J, Aschner M (2006) Methylmercury induces oxidative injury, alterations in permeability and glutamine transport in cultured astrocytes
Suggested use: Take 2 capsules in a day with 2 dcl of water (preferably 30 min before meal)
[DOI] [PMC free article] [PubMed] [Google Scholar] 89.Vaisse C, Halaas JL, Horvath CM, Darnell JE, Stoffel M, Friedman JM